| Systematic review on role of structure based drug design (SBDD) in the identification of anti-viral leads against SARS-Cov-2 NG Bajad, S Rayala, G Gutti, A Sharma, M Singh, A Kumar, SK Singh Current Research in Pharmacology and Drug Discovery 2, 100026, 2021 | 32 | 2021 |
| Indole: A promising scaffold for the discovery and development of potential anti-tubercular agents NG Bajad, SK Singh, SK Singh, TD Singh, M Singh Current Research in Pharmacology and Drug Discovery 3, 100119, 2022 | 22 | 2022 |
| A systematic review of carbohydrate-based bioactive molecules for Alzheimer’s disease NG Bajad, R Swetha, G Gutti, M Singh, A Kumar, SK Singh Future Medicinal Chemistry 13 (19), 1695-1711, 2021 | 10 | 2021 |
| Discovery of triazole-bridged aryl adamantane analogs as an intriguing class of multifunctional agents for treatment of Alzheimer's disease G Gutti, J Leifeld, R Kakarla, NG Bajad, A Ganeshpurkar, A Kumar, ... European Journal of Medicinal Chemistry 259, 115670, 2023 | 8 | 2023 |
| Recent applications of bioinformatics in target identification and drug discovery for Alzheimer’s disease SK Singh, A Kumar, RB Singh, P Ghosh, NG Bajad Current topics in medicinal chemistry 22 (26), 2153-2175, 2022 | 8 | 2022 |
| Cathepsin BA neuronal death mediator in Alzheimer’s disease leading to neurodegeneration A Sharma, R Swetha, NG Bajad, A Ganeshpurkar, R Singh, A Kumar, ... Mini Reviews in Medicinal Chemistry 22 (15), 2012-2023, 2022 | 8 | 2022 |
| Recent Advances in the Development of Near-Infrared Fluorescent Probes for the in Vivo Brain Imaging of Amyloid-β Species in Alzheimer’s Disease NG Bajad, A Kumar, SK Singh ACS Chemical Neuroscience 14 (17), 2955-2967, 2023 | 5 | 2023 |
| Combined structure and ligand-based design of dual BACE-1/GSK-3β inhibitors for Alzheimer’s disease NG Bajad, R Swetha, R Singh, A Ganeshpurkar, G Gutti, RB Singh, ... Chemical Papers 76 (12), 7507-7524, 2022 | 5 | 2022 |
| Identification of potent histone deacetylase 2 (HDAC2) inhibitors through combined structure and ligand-based designs and molecular modelling approach A Anand, P Ghosh, R Singh, N Gajanan Bajad, A Kumar, SK Singh Journal of Biomolecular Structure and Dynamics 42 (9), 4679-4698, 2024 | 2 | 2024 |
| Development of multi-targetable chalcone derivatives bearing N-aryl piperazine moiety for the treatment of Alzheimer's disease NG Bajad, RB Singh, TA Gajendra, G Gutti, A Kumar, S Krishnamurthy, ... Bioorganic Chemistry 143, 107082, 2024 | 2 | 2024 |
| Identification of novel potential cathepsin-B inhibitors through pharmacophore-based virtual screening, molecular docking, and dynamics simulation studies for the treatment of … J Jangra, NG Bajad, R Singh, A Kumar, SK Singh Molecular Diversity, 1-21, 2024 | | 2024 |
| A systematic review of carbohydrate-based bioactive molecules for Alzheimer's disease (vol 13, pg 1695, 2021) NG Bajad, R Swetha, G Gutti, M Singh, A Kumar, SK Singh FUTURE MEDICINAL CHEMISTRY 14 (4), 289-294, 2022 | | 2022 |
Prof. Sushil Kumar Singh, FRSCDepartment of Pharmaceutical Engineering & Technology, IIT(BHU, Varanasi在 itbhu.ac.in 的电子邮件经过验证
